(VIANEWS) – MONTEA (MONT.BR), SPBK 1 ØSTLANDET (SPOL.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MONTEA (MONT.BR)
25.8% sales growth and 6.28% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specialises in logistical property in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space they need to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/03/2023 the property portfolio represented a total space of 1,889,054 m² spread across 92 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €4.22.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 16.68. Meaning, the purchaser of the share is investing €16.68 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.
More news about MONTEA.
2. SPBK 1 ØSTLANDET (SPOL.OL)
19% sales growth and 11.87% return on equity
SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. SpareBank 1 Østlandet operates as a subsidiary of Sparebankstiftelsen Hedmark.
Earnings Per Share
As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr13.36.
PE Ratio
SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 9.84. Meaning, the purchaser of the share is investing kr9.84 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.87%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 47.3% and 4.4%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.5%, now sitting on 4.91B for the twelve trailing months.
More news about SPBK 1 ØSTLANDET.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.44. Meaning, the purchaser of the share is investing kr31.44 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
Volume
Today’s last reported volume for NAVAMEDIC is 222940 which is 499.57% above its average volume of 37183.
More news about NAVAMEDIC.
4. SANDNES SPAREBANK (SADG.OL)
12% sales growth and 8.32% return on equity
Sandnes Sparebank, an independent savings bank, provides a range of banking and investment products to retail and corporate customers in Norway. It operates through three segments: Retail Market, Corporate Market, and Real Estate. The company offers fixed rate deposits, deposit accounts, BSU, and tax withholding and other accounts; child, death, income, critical illness, disability, car, home, cabin, contents, UNG, and other insurance products; and pension solutions. It also provides bank guarantee, overdrafts, leasing, construction and business loans, factoring and invoice sales; fixed interest, mortgage, car, and other vehicle loans, as well as small loans and refinancing, and green loans; bank and credit cards; various loans and guarantees; and mobile and internet banking services. In addition, the company offers real estate brokerage and general investment advisory services. Sandnes Sparebank was founded in 1875 and is headquartered in Sandnes, Norway.
Earnings Per Share
As for profitability, SANDNES SPAREBANK has a trailing twelve months EPS of kr5.16.
PE Ratio
SANDNES SPAREBANK has a trailing twelve months price to earnings ratio of 15.81. Meaning, the purchaser of the share is investing kr15.81 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.32%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 6.05 and the estimated forward annual dividend yield is 7.12%.
Volume
Today’s last reported volume for SANDNES SPAREBANK is 7139 which is 119.86% above its average volume of 3247.
Yearly Top and Bottom Value
SANDNES SPAREBANK’s stock is valued at kr81.60 at 22:20 EST, way below its 52-week high of kr97.80 and above its 52-week low of kr81.00.
Sales Growth
SANDNES SPAREBANK’s sales growth is 18.9% for the ongoing quarter and 12% for the next.
More news about SANDNES SPAREBANK.
5. SPAREBANK 1 SR-BK (SRBNK.OL)
6.2% sales growth and 13.14% return on equity
SpareBank 1 SR-Bank ASA, together with its subsidiaries, provides various financial products and services for personal and corporate customers in Southern and Western Norway. The company operates through Retail customers, SME & Agriculture, and Large Corporates segments. It offers its products and services in the areas of savings, loans, insurance, and pensions. The company also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, advisory, estate agency, payroll/HR, securities trading, and investments services; green loans; credit and debit cards; consulting; and banking services. In addition, it facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. Further, the company is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. It also serves retail and corporate, small business, and agricultural customers, as well as the public sector. The company was founded in 1839 and is headquartered in Stavanger, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SR-BK has a trailing twelve months EPS of kr14.19.
PE Ratio
SPAREBANK 1 SR-BK has a trailing twelve months price to earnings ratio of 8.85. Meaning, the purchaser of the share is investing kr8.85 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.
Sales Growth
SPAREBANK 1 SR-BK’s sales growth is 28.7% for the ongoing quarter and 6.2% for the next.
More news about SPAREBANK 1 SR-BK.
